These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 24646860)

  • 1. Contribution of the organic anion transporter OAT2 to the renal active tubular secretion of creatinine and mechanism for serum creatinine elevations caused by cobicistat.
    Lepist EI; Zhang X; Hao J; Huang J; Kosaka A; Birkus G; Murray BP; Bannister R; Cihlar T; Huang Y; Ray AS
    Kidney Int; 2014 Aug; 86(2):350-7. PubMed ID: 24646860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of Organic Anion Transporter 2 (SLC22A7): A Highly Efficient Transporter for Creatinine and Species-Dependent Renal Tubular Expression.
    Shen H; Liu T; Morse BL; Zhao Y; Zhang Y; Qiu X; Chen C; Lewin AC; Wang XT; Liu G; Christopher LJ; Marathe P; Lai Y
    Drug Metab Dispos; 2015 Jul; 43(7):984-93. PubMed ID: 25904762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of organic cation transporter OCT2 and multidrug and toxin extrusion proteins MATE1 and MATE2-K for transport and drug interactions of the antiviral lamivudine.
    Müller F; König J; Hoier E; Mandery K; Fromm MF
    Biochem Pharmacol; 2013 Sep; 86(6):808-15. PubMed ID: 23876341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No Inhibition of MATE1/2K-Mediated Renal Creatinine Secretion Predicted With Ritonavir or Cobicistat.
    Kikuchi R; Chiou WJ; Kasai MA; de Morais SM; Bow DAJ
    J Pharm Sci; 2019 Sep; 108(9):3118-3123. PubMed ID: 31034908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Nonmetabolized β-Blocker Nadolol Is a Substrate of OCT1, OCT2, MATE1, MATE2-K, and P-Glycoprotein, but Not of OATP1B1 and OATP1B3.
    Misaka S; Knop J; Singer K; Hoier E; Keiser M; Müller F; Glaeser H; König J; Fromm MF
    Mol Pharm; 2016 Feb; 13(2):512-9. PubMed ID: 26702643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the effect of cobicistat on the in vitro renal transport and cytotoxicity potential of tenofovir.
    Stray KM; Bam RA; Birkus G; Hao J; Lepist EI; Yant SR; Ray AS; Cihlar T
    Antimicrob Agents Chemother; 2013 Oct; 57(10):4982-9. PubMed ID: 23896476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of Organic Anion Transporter 2 and Organic Cation Transporter 2 in Creatinine Clearance: Mechanistic Evaluation Using Freshly Prepared Human Primary Renal Proximal Tubule Cells.
    Mathialagan S; Chung G; Pye K; Rodrigues AD; Varma MVS; Brown C
    J Pharmacol Exp Ther; 2024 Jan; 388(1):201-208. PubMed ID: 37977812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimation of changes in serum creatinine and creatinine clearance caused by renal transporter inhibition in healthy subjects.
    Nakada T; Kudo T; Kume T; Kusuhara H; Ito K
    Drug Metab Pharmacokinet; 2019 Aug; 34(4):233-238. PubMed ID: 31176593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Importance of OCT2 and MATE1 for the Cimetidine-Metformin Interaction: Insights from Investigations of Polarized Transport in Single- And Double-Transfected MDCK Cells with a Focus on Perpetrator Disposition.
    Müller F; Weitz D; Mertsch K; König J; Fromm MF
    Mol Pharm; 2018 Aug; 15(8):3425-3433. PubMed ID: 29975542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal tubular transporter-mediated interactions of HIV drugs: implications for patient management.
    Gutiérrez F; Fulladosa X; Barril G; Domingo P
    AIDS Rev; 2014; 16(4):199-212. PubMed ID: 25350530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal tubular secretion of pramipexole.
    Knop J; Hoier E; Ebner T; Fromm MF; Müller F
    Eur J Pharm Sci; 2015 Nov; 79():73-8. PubMed ID: 26360835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular mechanism of renal tubular secretion of the antimalarial drug chloroquine.
    Müller F; König J; Glaeser H; Schmidt I; Zolk O; Fromm MF; Maas R
    Antimicrob Agents Chemother; 2011 Jul; 55(7):3091-8. PubMed ID: 21518836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tucatinib Inhibits Renal Transporters OCT2 and MATE Without Impacting Renal Function in Healthy Subjects.
    Topletz-Erickson AR; Lee AJ; Mayor JG; Rustia EL; Abdulrasool LI; Wise AL; Dailey B; DeChenne S; Walker LN; Alley SC; Endres CJ
    J Clin Pharmacol; 2021 Apr; 61(4):461-471. PubMed ID: 32989831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of MATE1 to Renal Secretion of the NMDA Receptor Antagonist Memantine.
    Müller F; Weitz D; Derdau V; Sandvoss M; Mertsch K; König J; Fromm MF
    Mol Pharm; 2017 Sep; 14(9):2991-2998. PubMed ID: 28708400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact on creatinine renal clearance by the interplay of multiple renal transporters: a case study with INCB039110.
    Zhang Y; Warren MS; Zhang X; Diamond S; Williams B; Punwani N; Huang J; Huang Y; Yeleswaram S
    Drug Metab Dispos; 2015 Apr; 43(4):485-9. PubMed ID: 25605813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Renal Transporter Inhibition Using Creatinine as a Substrate In Vitro to Assess the Clinical Risk of Elevated Serum Creatinine.
    Mathialagan S; Rodrigues AD; Feng B
    J Pharm Sci; 2017 Sep; 106(9):2535-2541. PubMed ID: 28416419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Competitive inhibition of the luminal efflux by multidrug and toxin extrusions, but not basolateral uptake by organic cation transporter 2, is the likely mechanism underlying the pharmacokinetic drug-drug interactions caused by cimetidine in the kidney.
    Ito S; Kusuhara H; Yokochi M; Toyoshima J; Inoue K; Yuasa H; Sugiyama Y
    J Pharmacol Exp Ther; 2012 Feb; 340(2):393-403. PubMed ID: 22072731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory Effects of Green Tea and (-)-Epigallocatechin Gallate on Transport by OATP1B1, OATP1B3, OCT1, OCT2, MATE1, MATE2-K and P-Glycoprotein.
    Knop J; Misaka S; Singer K; Hoier E; Müller F; Glaeser H; König J; Fromm MF
    PLoS One; 2015; 10(10):e0139370. PubMed ID: 26426900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In Vitro Inhibition of Renal OCT2 and MATE1 Secretion by Antiemetic Drugs.
    George B; Wen X; Jaimes EA; Joy MS; Aleksunes LM
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34208557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of clinical drug-drug interactions of veliparib (ABT-888) with human renal transporters (OAT1, OAT3, OCT2, MATE1, and MATE2K).
    Kikuchi R; Lao Y; Bow DA; Chiou WJ; Andracki ME; Carr RA; Voorman RL; De Morais SM
    J Pharm Sci; 2013 Dec; 102(12):4426-32. PubMed ID: 24122511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.